SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike M who wrote (656)6/4/1999 10:11:00 AM
From: DanZ  Read Replies (2) of 5582
 
Mike,

I agree that publication of Zicam in the NEJM would put a big fire under the stock. There are some other things could push the stock up in the meantime, however. The gum business is doing well and the prospects for nicotine gum should provide a lot of interest for the stock. The trade show in New Orleans could bring in some new buyers as they learn about Zicam and new gum products that will be shown.

This stock is not for short term traders but I am confident that long term holders will make a lot of money with it. Day trading is good for small gains, but I think GUMM will trade to at least 30 in the next 6 to 9 months and that wouldn't be easy to duplicate with short term trading. I'm not knocking short term trading as I trade a lot myself, but a mix of long term holds and short term trading is a good strategy, IMO. One of these days we are going to wake up to some big pre-open news and those who aren't already in will find themselves chasing the stock.

Dan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext